7 Voted
LLLT in the Lancet Top 20 Hit Parade

Posted on 21 August 2010 by James Carroll

The paper by Roberta Chow, Mark Johnson, Rodrigo Lopes-Martins, Jan M Bjordal titled “Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials” (abstract here) reached number 17 in The Lancet top 20 most downloaded papers for 2010. The full top 20 list is here:

1. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

2. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

3. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

4. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

5. Biological, clinical, and ethical advances of placebo effects

6. Clinical assessment incorporating a personal genome

7. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

8. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

9. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

10. Ticagrelor in ACS: redefining a new standard of care?

11. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial

12. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

13. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

14. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension

15. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

16. Ageing populations: the challenges ahead

17. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials

18. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

19. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

20. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials


THE LANCET ® is a registered trademark of Elsevier Properties SA, used under license.

About James Carroll

THOR Photomedicine Founder and CEO Editor of the "Literature Watch" on PMLS Speaker on dose rate effects of light & NIR radiation Fellow of the Royal Society of Medicine Assoc Member Institute of Physics
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>